Landec Corporation (LNDC) Stock Grade

About Landec Corporation's fundamentals

Landec Corporation is a specialty and generic drug manufacturer with a market capitalization of $263.6 million that has demonstrated solid revenue growth of 9.8% year-over-year. However, the company is currently unprofitable, reporting an 18.4% net margin loss in its latest annual statement, which explains why a P/E ratio is not available. Despite the accounting losses, the company is generating positive free cash flow, suggesting operational cash generation from its business activities. The company offers a modest dividend yield of 0.6% to shareholders.